Matsumoto; Mitsunobu
Patent Applications and Registrations
Patent applications and USPTO patent grants for Matsumoto; Mitsunobu.The latest application filed is for "pharmaceutical composition for cancer treatment".
- Matsumoto; Mitsunobu - Toyonaka-shi JP
- Matsumoto; Mitsunobu - Toyonaka JP
| Patent | Date |
|---|---|
| Pharmaceutical Composition for Cancer Treatment App 20210115148 - Yoshida; Tetsuya ; et al. | 2021-04-22 |
| Pharmaceutical Composition for Cancer Treatment App 20210047421 - Yoshida; Tetsuya ; et al. | 2021-02-18 |
| Pharmaceutical Composition for Cancer Treatment App 20200232973 - Yoshida; Tetsuya ; et al. | 2020-07-23 |
| Pharmaceutical Composition for Cancer Treatment App 20200222463 - Yoshida; Tetsuya ; et al. | 2020-07-16 |
| Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8 Grant 10,550,191 - Yoshida , et al. Fe | 2020-02-04 |
| Pharmaceutical Composition For Cancer Treatment App 20190071508 - YOSHIDA; Tetsuya ; et al. | 2019-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 